Home/Micar Innovation/Miguel Rivera
MR

Miguel Rivera

Management Team

Micar Innovation

Micar Innovation Pipeline

DrugIndicationPhase
PPARγ ProgramMetabolic DisordersDiscovery
AKT1 Inhibitor ProgramOncologyDiscovery
GlyT2 Inhibitor ProgramNeurological DisordersDiscovery
Cardiovascular Target ProgramHypertrophic CardiomyopathyDiscovery